Barclays’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Barclays’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-15,000	Closed	-$585K	–	7986
2014 Q1	$585K	Sell	15,000 -15,000	-50%	-$671K	﹤0.01%	3802
2013 Q4	$1.11M	Buy	+30,000	New	+$1.24M	﹤0.01%	3288

Barclays's KYTH Position: Q4 2015 in Review

Barclays sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 251,154 shares — an estimated $18.6M sold.

Barclays first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $19.9M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Barclays reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Barclays sold 251,154 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $18.6M.
Barclays first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
Barclays's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $19.9M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Barclays's 13F filing for Q4 2015, filed 12 Feb 2016.